Clinical trials
Phase 2 Liver Cirrhosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 7 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Gilead Sciences | 3 |
| Axcella Health, Inc | 1 |
| Celgene | 1 |
| Conatus Pharmaceuticals Inc. | 1 |
| European Foundation for Study of Chronic Liver Failure | 1 |
| Imperial College London | 1 |
| Nottingham University Hospitals NHS Trust | 1 |
| Novartis Pharmaceuticals | 1 |
| Tobira Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 16 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Fibrosis | 3 |
| Liver Diseases | 2 |
| Acute-On-Chronic Liver Failure | 1 |
| Cholangitis, Sclerosing | 1 |
| End Stage Liver Disease | 1 |
| Fatty Liver | 1 |
| Hepatic Encephalopathy | 1 |
| Hepatitis, Alcoholic | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.